[
    [
        {
            "time": "2018-02-12",
            "original_text": "Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO",
            "features": {
                "keywords": [
                    "Health Care",
                    "Sector Update",
                    "AXON",
                    "UTHR",
                    "NVO",
                    "FOLD",
                    "AVEO"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Health Care Sector Update for 02/12/2018: AXON,UTHR,NVO,FOLD,AVEO",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-02-12",
            "original_text": "Noteworthy ETF Outflows: VEU, TD, SAP, NVO",
            "features": {
                "keywords": [
                    "ETF Outflows",
                    "VEU",
                    "TD",
                    "SAP",
                    "NVO"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Noteworthy ETF Outflows: VEU, TD, SAP, NVO",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-02-12",
            "original_text": "Blog Exposure - Novo Nordisk’s Ozempic is Approved in the EU for the Treatment of Type 2 Diabetes",
            "features": {
                "keywords": [
                    "Novo Nordisk",
                    "Ozempic",
                    "Approved",
                    "EU",
                    "Type 2 Diabetes"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Blog Exposure - Novo Nordisk’s Ozempic is Approved in the EU for the Treatment of Type 2 Diabetes",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-02-12",
            "original_text": "GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018",
            "features": {
                "keywords": [
                    "GlaxoSmithKline",
                    "Moody's",
                    "M&A",
                    "downside risk",
                    "European pharma",
                    "credit quality"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "GlaxoSmithKline plc -- Moody's: M&A greatest downside risk to European pharma companies' credit quality in 2018",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-02-12",
            "original_text": "Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY)",
            "features": {
                "keywords": [
                    "Better Buy",
                    "Pfizer",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Better Buy: Pfizer Inc. (PFE) vs. Eli Lilly (LLY)",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        }
    ]
]